Sanctura XR, a new long-acting formulation of trospium for overactive bladder
January 2008
You'll soon see Sanctura XR, a new long-acting formulation of trospium for overactive bladder.
It will compete with the other long-acting antimuscarinics...Ditropan XL and Oxytrol (oxybutynin)...Detrol LA (tolterodine)...Vesicare (solifenacin)...and Enablex (darifenacin).
These drugs seem to be similar in efficacy and cost. The big differences are the frequency of side effects and drug interactions.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote